Generation Pb Ratio vs Capex To Operating Cash Flow Analysis
GBIO Stock | USD 1.16 0.03 2.52% |
Generation Bio financial indicator trend analysis is much more than just examining Generation Bio latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Generation Bio is a good investment. Please check the relationship between Generation Bio Pb Ratio and its Capex To Operating Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Pb Ratio vs Capex To Operating Cash Flow
Pb Ratio vs Capex To Operating Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Generation Bio Pb Ratio account and Capex To Operating Cash Flow. At this time, the significance of the direction appears to have very week relationship.
The correlation between Generation Bio's Pb Ratio and Capex To Operating Cash Flow is 0.21. Overlapping area represents the amount of variation of Pb Ratio that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of Generation Bio Co, assuming nothing else is changed. The correlation between historical values of Generation Bio's Pb Ratio and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pb Ratio of Generation Bio Co are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Pb Ratio i.e., Generation Bio's Pb Ratio and Capex To Operating Cash Flow go up and down completely randomly.
Correlation Coefficient | 0.21 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Pb Ratio
Capex To Operating Cash Flow
Most indicators from Generation Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Generation Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. As of the 16th of December 2024, Selling General Administrative is likely to drop to about 31.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 34.2 M
2023 | 2024 (projected) | Depreciation And Amortization | 5.3M | 3.8M | Interest Income | 12.0M | 12.5M |
Generation Bio fundamental ratios Correlations
Click cells to compare fundamentals
Generation Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Generation Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 42.1M | 294.2M | 476.8M | 376.3M | 374.8M | 302.1M | |
Other Current Liab | 6.9M | 11.0M | 7.6M | 4.3M | 16.5M | 9.4M | |
Total Current Liabilities | 9.2M | 11.2M | 18.8M | 19.2M | 39.9M | 41.9M | |
Total Stockholder Equity | (98.6M) | 268.0M | 381.7M | 282.5M | 203.1M | 182.5M | |
Net Tangible Assets | (98.6M) | 268.0M | 381.7M | 282.5M | 324.9M | 174.3M | |
Property Plant And Equipment Net | 21.8M | 23.8M | 91.0M | 81.4M | 95.7M | 58.3M | |
Net Debt | (15.1M) | (62.9M) | (294.3M) | (11.5M) | 31.4M | 33.0M | |
Retained Earnings | (108.5M) | (189.0M) | (308.1M) | (444.8M) | (571.4M) | (542.8M) | |
Accounts Payable | 2.3M | 267K | 2.0M | 662K | 2.3M | 1.7M | |
Cash | 15.1M | 62.9M | 375.1M | 93.2M | 66.4M | 113.7M | |
Non Current Assets Total | 24.0M | 26.4M | 97.6M | 89.2M | 102.1M | 63.4M | |
Non Currrent Assets Other | 87K | 588K | 864K | 2.1M | 698K | 863.6K | |
Other Assets | 2.1M | 2.6M | 6.6M | 7.8M | 9.0M | 4.7M | |
Cash And Short Term Investments | 15.1M | 262.3M | 375.1M | 279.1M | 264.4M | 233.0M | |
Net Receivables | 448K | 252K | 403K | 395K | 4.1M | 4.4M | |
Common Stock Shares Outstanding | 46.2M | 27.3M | 56.3M | 58.1M | 64.5M | 49.9M | |
Liabilities And Stockholders Equity | 42.1M | 294.2M | 476.8M | 376.3M | 374.8M | 302.1M | |
Non Current Liabilities Total | 131.6M | 14.9M | 76.2M | 74.6M | 131.7M | 73.0M | |
Capital Surpluse | 9.9M | 457.0M | 689.9M | 727.3M | 836.4M | 878.3M | |
Other Current Assets | 2.6M | 5.4M | 7.4M | 7.5M | 290K | 275.5K | |
Other Stockholder Equity | 9.9M | 162.8M | 689.9M | 727.3M | 774.2M | 434.4M | |
Total Liab | 140.7M | 26.1M | 95.0M | 93.8M | 171.6M | 119.6M | |
Net Invested Capital | (98.6M) | 268.0M | 381.7M | 282.5M | 203.1M | 182.5M | |
Property Plant And Equipment Gross | 21.8M | 23.8M | 25.9M | 22.2M | 115.3M | 121.1M | |
Total Current Assets | 18.2M | 267.7M | 379.2M | 287.0M | 272.6M | 238.6M | |
Net Working Capital | 9.0M | 256.5M | 360.4M | 267.9M | 232.7M | 219.4M | |
Property Plant Equipment | 21.8M | 23.8M | 25.9M | 22.2M | 25.5M | 21.6M |
Pair Trading with Generation Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Generation Stock
Moving against Generation Stock
0.85 | BMY | Bristol Myers Squibb | PairCorr |
0.79 | ESPR | Esperion Therapeutics | PairCorr |
0.78 | DYAI | Dyadic International | PairCorr |
0.65 | GILD | Gilead Sciences | PairCorr |
0.4 | DNA | Ginkgo Bioworks Holdings Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.